B+
Bull case
35%
Probability
Target price
$15.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
AFYA
AfyaBNasdaq / Consumer Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
40%
Probability
Target price
$12.00
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-02
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+36.1
Score
AI commentary
Transaction news dominates, but the October 1 anchor predates that evening's public posting of the voting agreement, so no post-posting price reaction can be attributed from this packet. The SEC-filed September 23 announcement had already disclosed the voting commitments; their later publication is not evidence of a new approval or closing. Verified analyst revisions and post-announcement target changes are unavailable. Social coverage, options skew, short interest and employee sentiment are unavailable; zero fields denote missing data, not neutral readings. The deterministic prior is neutral, with moderate evidence quality and low catalyst density.
RankAlpha Sentiment Codex - 2026-10-02
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-12-31event2026 guidance and margin deliveryMedium impact
First-half revenue rose 7.0%, while adjusted EBITDA rose 2.8% and adjusted EBITDA margin fell 190 basis points to 46.2%. Afya reaffirmed 2026 revenue guidance of R$3.95–4.10 billion and adjusted EBITDA guidance of R$1.70–1.80 billion. Subsequent results will test whether investment spending supports growth without further margin erosion. [#PR-2026-08-13] Afya SEC-filed results
2027-06-30catalystMedical-seat and tuition conversionMedium impact
Afya reported 3,768 operating medical seats and 3.9% growth in medical-school net average ticket in the first half. A later authorization added 17 seats at Cruzeiro do Sul, bringing approved seats to 3,785. Enrollment and revenue conversion, rather than authorization alone, are the relevant tests. [#PR-2026-08-13] Afya SEC-filed results [#PR-2026-09-18] Afya SEC-filed seat announcement
2028-03-31eventYduqs merger approvals and exchange valueHigh impact
Afya's signed merger would exchange each Afya share for 6.408347 new Yduqs shares. Major shareholders committed on September 23 to vote in favor, but shareholder and Brazilian antitrust approvals remain outstanding. Closing is contemplated no later than March 31, 2028, subject to extensions; this is not a cash offer or a completed transaction. [#PR-2026-09-23] Afya SEC-filed announcement
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-02 • Updated nightlySource: Internal modelMethodology